pravastatin has been researched along with omega-n-methylarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, K; Eshima, K; Hironaga, K; Hirooka, Y; Masumoto, A; Setoguchi, S; Takeshita, A | 1 |
| Bayerle-Eder, M; Bischof, MG; Fuchsjäger-Mayrl, G; Polska, E; Roden, M; Schmetterer, L; Sieder, A; Stulnig, T; Waldhäusl, W; Wolzt, M | 1 |
2 trial(s) available for pravastatin and omega-n-methylarginine
| Article | Year |
|---|---|
Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).
Topics: Acetylcholine; Anticholesteremic Agents; Cholesterol; Coronary Artery Disease; Endothelium, Vascular; Forearm; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pravastatin; Vasodilation; Vasodilator Agents | 2001 |
Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia.
Topics: Australia; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Kidney; Male; Middle Aged; omega-N-Methylarginine; Pravastatin; Time Factors; Triglycerides | 2002 |